Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients
Applying the 2021 VWD guidelines leads to improved diagnosis and management of symptomatic patients with 'Low VWF' as they are now classified as Type 1 VWD and receive optimal care with increased use of haemostatic therapy.
Authors
- Michael Dong (ORCID: https://orcid.org/0000-0001-7044-6030)
- Lakshmi Srivaths (ORCID: https://orcid.org/0000-0002-5324-7053)
- Joanna G. Larson (ORCID: https://orcid.org/0000-0002-1401-7837)
- Sepideh Saroukhani (ORCID: https://orcid.org/0000-0001-7704-3728)
- Miguel Escobar
Institutions
- The University of Texas Health Science Center (US)
- Indiana Hemophilia and Thrombosis Center (US)
Publication Details
- Journal
- Haemophilia
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1111/hae.70275
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00